$DGX News

Quest Diagnostics Upgraded After Strong Q3, While Also Announcing New Test For Alzheimer's

Quest Diagnostics (DGX) Stock Price Stalls After Strong Q3 Earnings

Quest Diagnostics (DGX) Backs At Home Cervical Cancer Screening

Quest Diagnostics (DGX) Stock Could Be Undervalued Despite Raised Full Year Guidance

Lab testing giant Quest Diagnostics confirms patients’ personal and health data was compromised during breach

Was Quest's 'Good Enough' Third Quarter Actually Good Enough?

What Quest Diagnostics (DGX) Said on Its Q3 Earnings Call

Quest Diagnostics (DGX) Q3 2026 Earnings Call Transcript

Quest Diagnostics Incorporated Q3 2026 Earnings Call Summary

DGX Q3 Earnings & Revenues Beat, '26 View Raised, Stock Down in Pre-Market

Why Quest's 'Good Enough' Third Quarter Wasn't Actually Enough

Quest Diagnostics Incorporated Reports Unauthorized Access to Quanum LSM System on October 21, 2026

Quest Diagnostics Reports Third Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

Quest Diagnostics Bumps Guidance While Managing Quanum System Breach

Quest’s (NYSE:DGX) Q3 2026: beats on revenue

Quest Diagnostics (DGX) Q3 Earnings and Revenues Beat Estimates

Quest Diagnostics: Q3 Earnings Snapshot

Quest Diagnostics Reports Third Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

Quest Diagnostics Q3 2026 Earnings Call Transcript

Quest Diagnostics Discloses Unauthorized Access To Its Testing Management Platform Quanum LSM System; Company Promptly Initiated Its Cybersecurity Incident Response Procedures To Contain The Activity; Sees No Material Disruption